Top Markets
#1 EXOD EXOD +56.80%
#2 Glidr Glidr +32.72%
#3 Fabric Protocol Fabric Protocol +23.80%
#4 Cysic Cysic +20.00%
#5 Nockchain Nockchain +19.55%
#6 Bedrock Bedrock +17.90%
#7 Epic Chain Epic Chain +12.10%
#8 Perle Perle +11.39%
#9 FOLKS FOLKS +8.38%
#10 The Black Bull The Black Bull +8.04%
Coin of the day
EXOD EXOD
Settings
Language
ENGLISH
Currency
USD
Theme
Evgen Pharma plc Evgen Pharma plc

Evgen Pharma plc

EVG
Rank in Stocks #38016
Evgen Pharma plc, a UK-based pharmaceutical company founded in 2014, operates... Evgen Pharma plc, a UK-based pharmaceutical company founded in 2014, operates at the clinical development stage, concentrating on the creation of sulforaphane-based medications. Its mission is to combat various cancers and inflammatory conditions. The firm utilizes its proprietary Sulforadex technology, which is engineered to stabilize sulforaphane, in its product development. SFX-01 stands as their principal drug candidate, currently in Phase II clinical trials for metastatic breast cancer and Phase Ib/IIa trials for glioblastoma. Furthermore, SFX-01 is being investigated in preclinical stages for haematological malignancies and analogous disorders. The company also offers out-licensing services for its innovative technology.
Share Price
$0.00953895
Last synced: 2024-05-22
Market Cap
$1.28M
Change (1 day)
0.06%
Change (1 year)
0.00%
Country
GB
Trade Evgen Pharma plc (EVG)

Category

Healthcare
Number of shares outstanding for Evgen Pharma plc (EVG)
Number of shares outstanding as of August 2026: 0
According to Evgen Pharma plc latest financial reports and stock price the company's current number of shares outstanding is 0. At the end of August 2026 the company had 0 shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.
Shares outstanding history for Evgen Pharma plc (EVG) from 2026 to 2026
Shares Outstanding at the end of each year
Year Shares Outstanding Change
Not enough data for the provided dates.
Shares Outstanding for similar companies or competitors
Company Shares Outstanding Difference Country
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 253.90M -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 62.19M -
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 - -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 0.00 -
BE